Abound Wealth Management

SEC CIK: 0001950323
Latest filing: Jul 10, 2026

SEC filings (opens in a new tab)

CYTK holding history

Cytokinetics Inc in every 13F filed by Abound Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overview All 13F holders of CYTK Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2023

Holdings of CYTK by Abound Wealth Management, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−14−100.0%	Sold out	Holders
Q4 2023	14	$1.17K	<0.1%	+3+27.3%	Added	Holders
Q3 2023	11	$325	<0.1%	00.0%	Unchanged	Holders
Q2 2023	11	$359	<0.1%	+11	New	Holders